{"id":"https://openalex.org/W4392723014","doi":"https://doi.org/10.1158/1535-7163.c.6537975","title":"Data from Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma","display_name":"Data from Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392723014","doi":"https://doi.org/10.1158/1535-7163.c.6537975"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6537975","doi":"https://doi.org/10.1158/1535-7163.c.6537975","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6537975","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.c.6537975","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007697804","display_name":"Parag P. Patwardhan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Parag P. Patwardhan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029552550","display_name":"Elgilda Musi","orcid":"https://orcid.org/0000-0002-2779-2322","observed_orcids":["https://orcid.org/0000-0002-2779-2322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elgilda Musi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12278","display_name":"Vascular Tumors and Angiosarcomas","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":1.0},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.9089999794960022},{"id":"https://openalex.org/keywords/synovial-sarcoma","display_name":"synovial sarcoma","score":1.0},{"id":"https://openalex.org/keywords/angiokinase-inhibitors","display_name":"angiokinase inhibitors","score":0.7490000128746033},{"id":"https://openalex.org/keywords/pdgfr","display_name":"PDGFR","score":0.7580000162124634},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.9729999899864197},{"id":"https://openalex.org/keywords/fibroblast-growth-factor-receptor","display_name":"fibroblast growth factor receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.9599999785423279},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9629999995231628},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.7400000095367432},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.7210000157356262},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9449999928474426}],"concepts":[{"id":"https://openalex.org/C2776910622","wikidata":"https://www.wikidata.org/wiki/Q2619315","display_name":"Synovial sarcoma","level":3,"score":0.8390337824821472},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.7042749524116516},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.6834673285484314},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.668329119682312},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5842484831809998},{"id":"https://openalex.org/C136948725","wikidata":"https://www.wikidata.org/wiki/Q1458306","display_name":"Soft tissue","level":2,"score":0.45929116010665894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23879557847976685},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2207534909248352},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.0},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6537975","doi":"https://doi.org/10.1158/1535-7163.c.6537975","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6537975","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6537975","doi":"https://doi.org/10.1158/1535-7163.c.6537975","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6537975","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2889283542","https://openalex.org/W1527852087","https://openalex.org/W2777674964","https://openalex.org/W2061292442","https://openalex.org/W4391223053","https://openalex.org/W2096965934","https://openalex.org/W2183002501","https://openalex.org/W1969148752","https://openalex.org/W2001887671","https://openalex.org/W33748964"],"abstract_inverted_index":{"Abstract":[0],"Sarcomas":[1,25],"are":[2,26,30],"rare":[3],"cancers":[4,12],"that":[5,200],"make":[6],"up":[7],"about":[8],"1%":[9],"of":[10,38,41,43,89,130,152,163,183,195,201,231],"all":[11,63],"in":[13,69,75,132,140,144,146,174,179,189,192,211,214,234],"adults;":[14],"however,":[15],"they":[16],"occur":[17],"more":[18],"commonly":[19],"among":[20],"children":[21],"and":[22,29,73,77,93,113,120,167,191],"young":[23],"adolescents.":[24],"genetically":[27],"complex":[28],"often":[31,84],"difficult":[32],"to":[33,66,199,226],"treat":[34],"given":[35],"the":[36,44,127,188,217],"lack":[37],"clinical":[39,212,229],"efficacy":[40,129,194],"any":[42],"currently":[45],"available":[46],"therapies.":[47],"Receptor":[48],"tyrosine":[49],"kinases":[50,83],"(RTK)":[51],"such":[52],"as":[53,58,60,86],"c-Kit,":[54],"c-Met,":[55],"PDGFR,":[56,111],"IGF-1R,":[57],"well":[59],"FGFR":[61,114],"have":[62],"been":[64],"reported":[65],"be":[67],"involved":[68],"driving":[70],"tumor":[71,90,118,176],"development":[72],"progression":[74],"adult":[76],"pediatric":[78],"soft-tissue":[79,133],"sarcoma.":[80,185,215,238],"These":[81],"driver":[82],"act":[85],"critical":[87,116],"determinants":[88],"cell":[91,135,147],"proliferation":[92],"targeting":[94],"these":[95],"signal":[96],"transduction":[97],"pathways":[98,115],"remains":[99],"an":[100],"attractive":[101],"therapeutic":[102],"approach.":[103],"Nintedanib,":[104],"a":[105,223],"potent":[106],"triple":[107],"angiokinase":[108],"inhibitor,":[109,205],"targets":[110],"VEGFR,":[112],"for":[117],"angiogenesis":[119],"vasculature.":[121],"In":[122],"this":[123,220,232],"study,":[124],"we":[125],"evaluated":[126],"preclinical":[128],"nintedanib":[131,159,172,196],"sarcoma":[134],"lines.":[136],"Nintedanib":[137],"treatment":[138,157,170],"resulted":[139,173],"significant":[141,161,175],"antiproliferative":[142],"effect":[143],"vitro":[145,190],"lines":[148],"with":[149,158,171,208,236],"high":[150],"expression":[151],"RTK":[153],"drug":[154,233],"targets.":[155],"Furthermore,":[156],"showed":[160],"downregulation":[162],"downstream":[164],"phosphorylated":[165],"AKT":[166],"ERK1/2.":[168],"Finally,":[169],"growth":[177],"suppression":[178],"mouse":[180],"xenograft":[181],"model":[182],"synovial":[184,237],"Notably,":[186],"both":[187],"vivo":[193],"was":[197],"superior":[198],"imatinib,":[202],"another":[203],"multikinase":[204],"previously":[206],"tested":[207],"minimal":[209],"success":[210],"trials":[213],"Overall,":[216],"data":[218],"from":[219],"study":[221],"provide":[222],"strong":[224],"rationale":[225],"warrant":[227],"further":[228],"exploration":[230],"patients":[235],"Mol":[239],"Cancer":[240],"Ther;":[241],"17(11);":[242],"2329\u201340.":[243],"\u00a92018":[244],"AACR.":[245]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2024-03-13T00:00:00"}